Pfizer Stock Below 50-Day and 200-Day SMA: Buy the Dip or Exit Now?

PFE is trading below key moving averages as investors balance fading COVID-era sales against expectations for pipeline growth and deal-driven upside. The stock’s low valuation and high dividend are providing support, but near-term sentiment remains cautious given the earnings mix transition.

Analysis

PFE is trading below key moving averages as investors balance fading COVID-era sales against expectations for pipeline growth and deal-driven upside. The stock’s low valuation and high dividend are providing support, but near-term sentiment remains cautious given the earnings mix transition.